Vanda Pharmaceuticals Inc. (VNDA) is a publicly traded Healthcare sector company. As of May 21, 2026, VNDA trades at $6.15 with a market cap of $365.62M and a P/E ratio of -1.52. VNDA moved +2.92% today. Year to date, VNDA is -21.47%; over the trailing twelve months it is +39.19%. Its 52-week range spans $3.81 to $9.94. Analyst consensus is strong buy with an average price target of $16.75. Rallies surfaces VNDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VNDA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VNDA recently traded at $6.15. Market cap is $365.62M. P/E ratio is -1.52. Revenue is $217.78M.
| Metric | Value |
|---|---|
| Price | $6.15 |
| Market Cap | $365.62M |
| P/E Ratio | -1.52 |
| EPS | $-4.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.94 |
| 52-Week Low | $3.81 |
| Volume | 1.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $217.78M |
| Net Income | $-239.55M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $216.10M | $-220.47M | $-3.74 |
| 2023 | $192.64M | $2.51M | $0.04 |
| 2022 | $254.38M | $6.28M | $0.11 |
| 2021 | $268.68M | $33.15M | $0.60 |
4 analysts cover VNDA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.75.